肠易激综合征 (IBS) 诊断市场分析及预测(按规模、份额、增长、趋势)2028 年

  • Report Code : TIPRE00016657
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 185
Buy Now

Irritable Bowel Syndrome (IBS) Diagnostics Market to Grow at a CAGR of 5.9% to reach US$ 3,880.91 million from 2020 to 2028

Buy Now

 

2020 年肠易激综合征 (IBS) 诊断市场价值为 24.7061 亿美元,预计到 2028 年将达到 38.8091 亿美元;预计 2021 年至 2028 年的复合年增长率为 5.9%。

 

肠易激综合征 (IBS) 是一种胃肠道疾病,会导致胃部不适、腹泻和便秘。细菌或病毒引起的严重腹泻(胃肠炎)后可能会引发 IBS。IBS 也可能与肠道细菌过多(细菌过度生长)有关。经历过压力事件的人(尤其是在童年时期)往往会出现更多的 IBS 症状。IBS 诊断是通过病史、体检和影像学检查来完成的。然而,IBS 主要通过乳糖不耐症测试、细菌过度生长呼气测试、血液检查和粪便检查来诊断。这些测试基于便秘为主、腹泻为主或混合型等症状。它还可以通过各种影像学检查进行检测,例如 CT 扫描或 X 光、上消化道内窥镜检查和结肠镜检查。

肠易激综合征 (IBS) 诊断市场根据诊断、适应症和地域进行细分。按地域划分,市场分为北美、欧洲、亚太地区、中东和非洲以及南美和中美。该报告提供了对肠易激综合征 (IBS) 诊断市场的见解和深入分析,重点关注市场趋势、技术进步和市场动态等参数,以及对世界主要市场参与者的竞争格局的分析。    

 

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

肠易激综合征 (IBS) 诊断市场:

Irritable Bowel Syndrome (IBS) Diagnostics Market: Strategic Insights

Irritable Bowel Syndrome (IBS) Diagnostics Market
  • CAGR
    CAGR (2020 - 2028)
    5.9%
  • Market Size 2020
    US$ 2.47 Billion
  • Market Size 2028
    US$ 3.88 Billion

Market Dynamics

GROWTH DRIVERS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
FUTURE TRENDS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPPORTUNITIES
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX

Key Players

  • Commonwealth Diagnostics International
  • Genova Diagnostics
  • Gemelli Biotech
  • Prometheus Laboratories
  • Inova Diagnostics Inc
  • Biohit Oyj
  • Aerodiagnostics LLC
  • Metabolic Solutions Inc
  • Sysmex Corporation

Regional Overview

Regional And Country Scope
  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

Segment 1诊断(实验室检查、影像学检查)
    Segment2适应症(疼痛和痉挛,腹泻,便秘,交替性便秘和腹泻)
      Segment3地理(北美洲、欧洲、亚太地区、中东和非洲、南美洲和中美洲)

        肠易激综合征 (IBS) 诊断市场
        • Irritable Bowel Syndrome (IBS) Diagnostics Market
          复合年增长率(2020 - 2028 年)
          5.9%
        • 2020 年市场规模
          24.7 亿美元
        • 2028 年市场规模
          38.8 亿美元

        市场动态

        增长动力
        • 財政部
        • 財政部
        • 財政部
        未来的趋势
        • 財政部
        • 財政部
        • 財政部
        机会
        • 財政部
        • 財政部
        • 財政部

        关键人物;主力;重要一员

        •  
        • 英联邦诊断国际公司
        • 热那亚诊断公司
        • Gemelli 生物技术
        • 普罗米修斯实验室
        • Inova Diagnostics 公司
        • 百奥希特公司
        • 航空诊断有限责任公司
        • 代谢解决方案有限公司
        • 希森美康股份有限公司

        区域概况

        Irritable Bowel Syndrome (IBS) Diagnostics Market
        • 北美
        • 欧洲
        • 亚太
        • 南美洲和中美洲
        • 中东和非洲

        市场细分

        Irritable Bowel Syndrome (IBS) Diagnostics Market诊断
        • 实验室检查
        • 影像学检查
        Irritable Bowel Syndrome (IBS) Diagnostics Market指征
        • 疼痛和痉挛
        • 腹泻
        • 便秘
        • 便秘和腹泻交替发生
        Irritable Bowel Syndrome (IBS) Diagnostics Market地理
        • 北美
        • 欧洲
        • 亚太地区
        • 中东和非洲
        • 南美洲和中美洲
        • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

         

         

        市场洞察

        肠易激综合征是一种因排便习惯紊乱和腹痛引起的慢性胃肠道疾病。这种疾病也被称为痉挛性结肠、肠易激综合征、粘液性结肠炎和痉挛性结肠炎。肠易激综合征的症状包括腹痛、便秘、腹泻和痉挛。

         

        世界各地的人们都见证着肠易激综合征的发病率不断上升。根据国际胃肠病基金会发布的数据,在所有肠易激综合征患者中,约 40% 的人患有轻度 IBS,约 35% 的人患有中度 IBS,估计 25% 的人患有重度 IBS。食物过敏、胃肠炎的发展阶段、结肠不规律运动、结肠中血清素的异常成分以及轻度乳糜泻都是导致肠易激综合征的危险因素。根据 2018 年 NCBI 发表的一项研究,估计肠易激综合征每年影响美国约 10-16% 的人口。此外,根据 IBS 2016 年的全球影响报告,估计各个国家的平均患病率从法国和伊朗的 1.1% 到墨西哥的 35.5% 不等。拉丁美洲的患病率为 17.5%,亚洲为 9.6%,北美/欧洲/澳大利亚/新西兰为 7.1%,中东和非洲的患病率为 5.8%。肠易激综合征如此惊人的患病率可能会在预测期内推动肠易激综合征 (IBS) 诊断市场的发展。

        为了应对肠易激综合征,市场参与者正在采取建设性措施,制定计划,在民众中传播意识。例如,2018 年,Allergan PLC 和 Ironwood 合作推出了一个互动数字目的地平台,鼓励患者接受教育并采取行动。同样,2018 年 1 月,Commonwealth Diagnostics International, Inc. 与美国职业高尔夫球手 Rob Oppenheim 合作,提高人们对肠易激综合征 (IBS) 和小肠细菌过度生长 (SIBO) 的认识。

         

        FDA 批准数量不断增加以及诊断技术不断发展,为市场增长做出了巨大贡献

         

        预测期内,越来越多的 FDA 批准和诊断开发活动可能会加速肠易激综合征 (IBS) 诊断市场的增长。大多数老牌和新参与者都在开发和生产该疾病的诊断解决方案,这将导致市场上诊断解决方案的充足供应。例如,2020 年 2 月,Commonwealth Diagnostics International (CDI), Inc. 重新推出了 IBSchek,这是首个经过临床验证的混合型肠易激综合征 (IBS-D、IBS-M) 和腹泻为主的生物标志物血液检测,采用了新的家用毛细血管收集试剂盒。此外,2018 年 10 月,Gemelli Biotech 与 Cedars-Sinai 的医学相关科学与技术计划 (MAST) 合作推出了 IBS-smart,这是一项肠易激综合征 (IBS) 血液检测的创新。

        肠易激综合征 (IBS) 诊断市场预计将见证诊断解决方案的批准,这最终将对市场的增长产生积极影响。例如,2019 年 6 月,BÜHLMANN Laboratories AG 的 BÜHLMANN fCAL turbo 自动钙卫蛋白测试和 BÜHLMANN fCAL ELISA 钙卫蛋白测试获得了美国食品药品监督管理局 (FDA) 510(k) 批准。据公司估计,该测试预计将在全球市场上实现蓬勃发展的销售。

         

        诊断见解            

         

        根据诊断,全球肠易激综合征 (IBS) 诊断市场分为实验室测试和影像学测试。2020 年,实验室测试部分占据了市场的最大份额。此外,预计到 2028 年,该部分将占据最大的市场份额。市场增长主要归因于全球肠易激综合征 (IBS) 的患病率不断上升,由于排便习惯紊乱和腹痛,未来几年这种患病率可能会持续下去。这反过来又推动了全球对这些疾病的诊断需求。

         

        指示见解

         

        根据适应症,全球肠易激综合征 (IBS) 诊断市场细分为疼痛和痉挛、腹泻、便秘和交替性便秘和腹泻。疼痛和痉挛部分在 2020 年占据了最大的市场份额,预计到 2028 年将进一步占据市场主导地位。解痉药和抗抑郁药是用于治疗 IBS 疼痛和痉挛的药物。    

        产品发布和并购是全球肠易激综合征 (IBS) 诊断市场广泛采用的策略。以下列出了一些近期的关键产品开发:

        2020 年 2 月,Commonwealth Diagnostics International (CDI), Inc. 宣布重新推出 IBSchek,这是首个经过临床验证的针对腹泻型和混合型肠易激综合征 (IBS-D、IBS-M) 的生物标志物血液检测,采用新的家用毛细血管收集试剂盒。

        2019 年 1 月,Gemelli Biotech 宣布与总部位于科威特的 Advanced Medical German Co. (AMG) 建立合作伙伴关系,后者是中东地区领先的国际医疗产品和服务分销商之一。通过此次合作,AMG 将在科威特、阿联酋、卡塔尔、沙特阿拉伯、埃及和土耳其等中东和北非主要地区分销 Gemelli 专有的 IBS 诊断血液测试 ibs-smart。

        据估计,COVID-19 疫情将对肠易激综合征 (IBS) 诊断市场产生重大积极影响。全球大多数制药公司都在致力于开发 COVID-19 疫苗。此外,肠易激综合征 (IBS) 通常由 COVID-19 压力引发。因此,家庭检测试剂盒比实验室检测更可取,因为实验室服务可能会在疫情中不堪重负,预计这将在未来几个月对市场的其他部分产生积极影响。然而,由于全球运营暂停导致供应链中断,阻碍了市场增长。 

         

        肠易激综合征 (IBS) 诊断市场报告范围

        报告属性细节
        2020 年市场规模24.7 亿美元
        2028 年市场规模38.8亿美元
        全球复合年增长率(2020 - 2028)5.9%
        历史数据2018-2019
        预测期2021-2028
        涵盖的领域根据诊断
        • 实验室检查
        • 影像学检查
        按适应症
        • 疼痛和痉挛
        • 腹泻
        • 便秘
        • 便秘和腹泻交替发生
        覆盖地区和国家北美
        • 我们
        • 加拿大
        • 墨西哥
        欧洲
        • 英国
        • 德国
        • 法国
        • 俄罗斯
        • 意大利
        • 欧洲其他地区
        亚太
        • 中国
        • 印度
        • 日本
        • 澳大利亚
        • 亚太其他地区
        南美洲和中美洲
        • 巴西
        • 阿根廷
        • 南美洲和中美洲其他地区
        中东和非洲
        • 南非
        • 沙特阿拉伯
        • 阿联酋
        • 中东和非洲其他地区
        市场领导者和主要公司简介
        •  
        • 英联邦诊断国际公司
        • 热那亚诊断公司
        • Gemelli 生物技术
        • 普罗米修斯实验室
        • Inova Diagnostics 公司
        • 百奥希特公司
        • 航空诊断有限责任公司
        • 代谢解决方案有限公司
        • 希森美康股份有限公司
        • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

         

         

        肠易激综合征 (IBS) 诊断 – 市场细分

         

         

        根据诊断

         

        • 实验室检查
          • 乳糖不耐症测试
          • 细菌过度生长的呼气测试
          • 大便检查
          • 血液检查
        • 影像学检查
          • CT 扫描或 X 光检查
          • 上消化道内镜检查
          • 结肠镜检查

         

        按适应症

         

        • 疼痛和痉挛
        • 腹泻
        • 便秘
        • 便秘和腹泻交替发生

         

        按地理位置

         

        • 北美

          • 我们
          • 加拿大
          • 墨西哥
        • 欧洲

          • 法国
          • 德国
          • 英国
          • 意大利
          • 西班牙
          • 欧洲其他地区
        • 亚太地区 (APAC)

          • 中国
          • 日本
          • 印度
          • 澳大利亚
          • 韩国
          • 亚太其他地区
        • 中东和非洲 (MEA)

          • 沙特阿拉伯
          • 南非
          • 阿联酋
          • 中东和非洲其他地区
        • 南美洲和中美洲(SCAM)

          • 巴西
          • 阿根廷
          • 南美洲和中美洲其他地区

         

        公司简介

         

        • 英联邦诊断国际公司
        • 热那亚诊断公司
        • Gemelli 生物技术
        • 普罗米修斯实验室
        • Inova Diagnostics 公司
        • 百奥希特公司
        • 航空诊断有限责任公司
        • 代谢解决方案有限公司
        • 希森美康股份有限公司
        • Bühlmann 实验室股份公司

        Irritable Bowel Syndrome (IBS) Diagnostics Market Report Scope

        Report Attribute Details
        Market size in US$ 2.47 Billion
        Market Size by US$ 3.88 Billion
        Global CAGR 5.9%
        Historical Data 2018-2019
        Forecast period 2021-2028
        Segments Covered By 诊断(实验室检查、影像学检查)
        By 适应症(疼痛和痉挛,腹泻,便秘,交替性便秘和腹泻)
        By 地理(北美洲、欧洲、亚太地区、中东和非洲、南美洲和中美洲)
        Regions and Countries Covered 北美(美国、加拿大、墨西哥)
        • 北美(美国、加拿大、墨西哥)
        欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
        • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
        亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
        • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
        南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
        • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
        中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
        • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
        Market leaders and key company profiles
      • Commonwealth Diagnostics International
      • Genova Diagnostics
      • Gemelli Biotech
      • Prometheus Laboratories
      • Inova Diagnostics Inc
      • Biohit Oyj
      • Aerodiagnostics LLC
      • Metabolic Solutions Inc
      • Sysmex Corporation
      • Report Coverage
        Report Coverage

        Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

        Segment Covered
        Segment Covered

        This text is related
        to segments covered.

        Regional Scope
        Regional Scope

        North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

        Country Scope
        Country Scope

        This text is related
        to country scope.

        Frequently Asked Questions


        What are the driving factors for the irritable bowel syndrome (IBS) diagnostics market across the globe?

        The factors that are driving growth of the market are increasing prevalence of irritable bowel syndrome and associated conditions and increasing number of FDA approvals and diagnostics developments are anticipated to drive the growth of the global irritable bowel syndrome (IBS) diag nostics market during the forecast period. However, challenges in diagnosis of IBS are hindering the market growth.

        Who are the major players in the irritable bowel syndrome (IBS) diagnostics market?

        The irritable bowel syndrome (IBS) diagnostics market majorly consists of the players such Commonwealth Diagnostics International, Genova Diagnostics, Gemelli Biotech, Prometheus Laboratories, Inova Diagnostics, Inc., Biohit Oyj, Aerodiagnostics, LLC., Metabolic Solutions, Inc., Sysmex Corporation, BÃœHLMANN Laboratories AG are among others.

        What is irritable bowel syndrome (IBS) diagnostics?

        Irritable bowel syndrome (IBS) is defined as gastro-intestinal disorder causing discomfort in the stomach, along with wind, diarrhoea and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. IBS might also be associated with a surplus of bacteria in the bowels (bacterial overgrowth). People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS. Moreover, IBS diagnostics is done through medical history, physical exam and imaging tests. However, IBS is majorly diagnosed by lactose intolerance tests, breath test for bacterial overgrowth, blood test and stool test. The tests are done based on the symptoms such as constipation-predominant, diarrhea-predominant or mixed. It can also detect by various imaging tests such as CT Scan or X-ray, upper endoscopy and colonoscopy.

        The List of Companies - Irritable Bowel Syndrome (IBS) Diagnostics Market

        1. Commonwealth Diagnostics International
        2. Genova Diagnostics
        3. Gemelli Biotech
        4. Prometheus Laboratories
        5. Inova Diagnostics, Inc.
        6. Biohit Oyj
        7. Aerodiagnostics, LLC.
        8. Metabolic Solutions, Inc.
        9. Sysmex Corporation
        10. BÜHLMANN Laboratories AG.

        The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

        1. Data Collection and Secondary Research:

        As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

        Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

        1. Primary Research:

        The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

        For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

        A typical research interview fulfils the following functions:

        • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
        • Validates and strengthens in-house secondary research findings
        • Develops the analysis team’s expertise and market understanding

        Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

        • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
        • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

        Below is the breakup of our primary respondents by company, designation, and region:

        Research Methodology

        Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

        1. Data Analysis:

        Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

        • Macro-Economic Factor Analysis:

        We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

        • Country Level Data:

        Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

        • Company Profile:

        The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

        • Developing Base Number:

        Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

        1. Data Triangulation and Final Review:

        The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

        We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

        We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

        Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

        Trends and growth analysis reports related to Medical Device : READ MORE..